Skip Navigation
  Search Menu
Find an Expert

 

Jeffrey Alan Tornheim, M.D., M.P.H.

Photo of Dr. Jeffrey Alan Tornheim, M.D., M.P.H.

Assistant Professor of Medicine

Background

Jeff Tornheim, MD, MPH, is Assistant Professor in the Division of Infectious Diseases here at Johns Hopkins University School of Medicine. His research explores the application of new diagnostic technologies to improved health outcomes in the treatment of drug resistant tuberculosis among both adult and pediatric patients in India.

Dr. Tornheim completed a clinical fellowship in Infectious Diseases at Johns Hopkins after a combined residency in both internal medicine and pediatrics at Yale University School of Medicine.  He received a BA in International Development and Economics from Brandeis University before moving to East Africa to work on strengthening health systems for returning refugees to South Sudan.  In addition, he worked with the Centers for Disease Control and Prevention (CDC) International Emerging Infections Program on the epidemiology of pneumonia and diarrhea in Western Kenya. He received an MD/MPH from Mount Sinai School of Medicine, with thesis work evaluating the impact of water policy on rates of pediatric diarrhea in Bolivia. At the same time he worked at the Bureau of TB Control for the Department of Health and Mental Hygiene and was actively engaged in the operations of an East Harlem free clinic. Before finishing medicine, he worked in rural Bolivia to establish and manage operations for a Chagas Disease treatment program through the Fogarty International Clinical Scholars Program.  His interest in clinical outcomes for underserved populations led him to practice in physician training environments in Bolivia, Peru, South Sudan, Kenya, Uganda, Rwanda, South Africa, and the United States.

He currently works with Drs. Amita Gupta, Kelly Dooley, Petros Karakousis, Vidya Mave, Bob Bollinger at Johns Hopkins.  His primary research activities include the epidemiology and microbiology of multidrug resistant tuberculosis (MDR-TB) in India, the use of whole genome sequencing as a tool to predict drug resistance and assess strain-relatedness for MDR-TB, and biomarkers of TB diagnosis and response to TB treatment.

...read more

Titles

  • Assistant Professor of Medicine

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD, Mount Sinai School of Medicine (2010)

Residencies

  • Yale-New Haven Hospital / Internal Medicine/Pediatrics (2014)

Fellowships

  • Johns Hopkins University School of Medicine / Infectious Diseases (2017)

Board Certifications

  • American Board of Internal Medicine / Infectious Disease (2016)
  • American Board of Internal Medicine / Internal Medicine (2014)
  • American Board of Pediatrics / Pediatrics (2014)

Research & Publications

Research Summary

Dr. Tornheim's research explores whether a combination of MDR-TB drug susceptibility tests using whole genome sequencing and minimum inhibitory concentrations can yield personalized treatment options for improved MDR-TB treatment outcomes.

Selected Publications

Ajbani K, Kazi M, Tornheim J, Naik S, Soman R, Shetty A, Rodrigues C. "Pyrosequencing to resolve discrepant Xpert MTB/RIF and Mycobacterial Growth Indicator Tube 960." Lung India. 2018 Mar-Apr;35(2):168-170. doi: 10.4103/lungindia.lungindia_71_17.

Tornheim JA, Dooley KE. "Tuberculosis associated with HIV infection." Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0028-2016. Review.

Activities & Honors

Honors

  • W. Leigh Thompson Excellence in Research: Clinical Research Faculty Award, Johns Hopkins Department of Medicine, 2018
  • Fogarty International Clinical Scholar, National Institutes of Health, 2016 - 2017
  • Fellow Teaching Award, Hopkins Bayview Medical Housestaff Training Program
  • Clinician Scientist Career Development Award, Johns Hopkins University School of Medicine

Videos & Media

Lectures and Presentations

  • Linezolid Experience Among MDR-TB Patients in Mumbai
    Presentation, 2018 Research Retreat, Baltimore, MD (03/16/2018)
    Johns Hopkins Department of Medicine
  • Linezolid Experience Among MDR-TB Patients in Mumbai
    Presentation, RePORT India Annual Meeting, New Delhi, India (02/15/2018)
  • Drug Susceptibility of Rifampin-resistant Tuberculosis using Whole Genome Sequencing to Identify Genes of Interest in Pune, India
    Presentation, RePORT India Annual Meeting, New Delhi, India (02/15/2018)
  • Drug Susceptibility of Rifampin-resistant Tuberculosis using Whole Genome Sequencing to Identify Genes of Interest in Pune, India
    Presentation, 48th Annual Union World Conference of Lung Health, Guadalajara, Mexico (10/12/2017)
  • Linezolid Experience among MDRTB Patients in Mumbai, ERS International Congress.
    Presentation, European Respiratory Society,, Milan, Italy (09/13/2017)

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 

Comments

Loading...
Is this you? Edit Profile